...
首页> 外文期刊>臨床血液 >Severe hyponatremia with consciousness disturbance caused by hydroxyurea in a patient with chronic myeloid leukemia
【24h】

Severe hyponatremia with consciousness disturbance caused by hydroxyurea in a patient with chronic myeloid leukemia

机译:慢性粒细胞白血病患者的严重低钠血症与羟基脲引起的意识障碍

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A 79-year-old man was admitted because of consciousness disturbance on August 9, 2002. He had been diagnosed as having chronic myeloid leukemia in 1999, and since then, he had continued to take hydroxyurea (1500 mg/day) orally. On admission, his serum sodium concentration was as low as 119 mEq/L, while urinary sodium excretion was high. Based on the blood picture and lack of hepatosplenomegaly, we considered that the leukemia was still in the chronic phase. Because of normal blood level of the antidiuretic hormone (ADH) concentration and sufficient urine volume, the syndrome of inappropriate ADH secretion (SIADH) was unlikely, and sodium-losing nephropathy was suspected. After discontinuation of hydroxyurea, the urinary sodium excretion decreased and the patient's consciousness became clear concomitantly with improvement in the serum Na level. This patient appears to be the first case of hyponatremia caused by hydroxyurea.
机译:2002年8月9日,一名79岁的男子因意识障碍而入院。他于1999年被诊断为患有慢性粒细胞白血病,此后他继续口服羟基脲(1500毫克/天)。入院时,他的血清钠浓度低至119 mEq / L,而尿钠排泄高。根据血象和肝脾肿大的缺乏,我们认为白血病仍处于慢性期。由于抗利尿激素(ADH)浓度的正常血液水平和足够的尿液量,不太可能出现不适当的ADH分泌综合征(SIADH),并怀疑有钠丢失性肾病。停用羟基脲后,尿钠排泄减少,并且患者的意识随着血清钠水平的改善而变得清晰。该患者似乎是羟基脲引起的低钠血症的第一例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号